PBT2 and zinc work together to fight antibiotic resistance, page-47

I'm new to Prana, 

Taking a bit of getting my head around the structure of this. It appears CEO remuneration is high. What is the justification behind this after such a long time? I cant find a reason in the chart history. Cash burn on wages without growth does not usually end well.

Has anyone brought this up at an AGM? Have they had a first or second remuneration strike?

I like what Rik Holliday Smith has done with Qbiotics, He came in with a clear structure to move the company forward and only work for options set at double the share price.

Hopefully Sinclair can bring a change of culture to the company and get the share price back up for everyone.